Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in AURA — Aura Biosciences, Inc.

CIK 70858 CHARLOTTE, NC
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$618,849
-$219,782 QoQ
Shares Held
87,162
-30.5% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 146 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. AURA ranks #234 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in AURA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $618,849 87,162
2026-03-31 $838,631 125,356
2025-12-31 $900,257 165,185
2025-09-30 $223,609 36,183
2025-06-30 $160,462 25,633
2025-03-31 $183,323 31,284
2024-12-31 $421,570 51,286
2024-09-30 $379,360 42,577
2024-06-30 $279,682 36,995
2024-03-31 $274,223 34,933
2023-12-31 $314,174 35,460
2023-09-30 $367,976 41,023
2023-06-30 $540,990 43,805
2023-03-31 $381,342 41,093
2022-12-31 $285,757 27,215
2022-09-30 $819,730 45,239
2022-06-30 $500,810 35,343
2022-03-31 $260,854 11,857
2021-12-31 $131,187 7,726